Amniotic Membrane for Donor Site Healing
Public ClinicalTrials.gov record NCT02947737. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
Investigating the Effects of Amniotic Membrane on Donor Site Healing and Postoperative Pain
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
The purpose of this study is to compare the effectiveness of applying amniotic membrane dressings compared to gentamicin and xeroform dressings to donor sites for skin grafts. This study will enroll ten participants who undergoing a split thickness skin graft procedure with two or more donor sites. The amniotic membrane will be applied to one donor site and a dressing of xeroform and gentamicin will be applied to another other donor site. Each participant will receive both types of dressing and will serve as their own control. Postoperative follow up will follow standard of care, regardless of the dressing type. Dressings will be removed on postoperative day 4 and participants will return to be re-examined one week after being discharged from the hospital.
Study identification
- NCT ID
- NCT02947737
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Not applicable
- Enrollment
- 4 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Jan 31, 2017
- Primary completion
- Aug 30, 2017
- Completion
- Aug 30, 2017
- Last update posted
- May 20, 2018
2017
United States locations
- U.S. sites
- 1
- U.S. states
- 1
- U.S. cities
- 1
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Grady Health System | Atlanta | Georgia | 30303 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Recently updated Burns trials
Other public records listing Burns. Sorted by last update posted; newest first. Not a recommendation.
- NCT06503406: A Prospective Study Using SupraSDRM® in Promoting Healing and Reducing the Time to Grafting of Full-thickness Wounds Recruiting
- NCT06857448: Autologous Point-of-Care Adipose Therapy: Recent Injury Recruiting
- NCT06857435: Autologous Point-of-Care Adipose Therapy: Delayed Injury/Scar Recruiting
- NCT07656545: Early Intervention to Prevent Development of PTSD in Burn Survivors and Their Caregivers Not yet recruiting
- NCT07494773: Topical Methylene Blue-Photodynamic Therapy (MB-PDT) for Burn Wound Infection Not yet recruiting
- NCT01297400: Phase 2 Pilot Study of the Safety and Efficacy of Topical MW-III in Thermal Burns Recruiting
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT02947737, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted May 20, 2018 · Synced Sep 16, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT02947737 live on ClinicalTrials.gov.